Trial Profile
A double-blind, placebo-controlled crossover study to investigate 'waiting impulsivity' in cocaine addiction and to evaluate the effect of atomoxetine mediated by genotype.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Aug 2023
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Cocaine-related disorders
- Focus Therapeutic Use
- 26 Oct 2015 New trial record
- 01 Sep 2015 Results presented at the 28th Annual Congress of the European College of Neuropsychopharmacology
- 29 Aug 2015 Results published on 28th Annual Congress of the European College of Neuropsychopharmacology